Our findings reveal significantly elevated expression of lncRNA H19 in TMZ-resistant compared to TMZ-sensitive GBM patients (50), a trend similarly observed in constructed TMZ-resistant GBM cell lines. This evidence concerns the gene H19 and glioblastoma.